Research Topics
Species | Brian KirkpatrickSummaryAffiliation: Scott and White Memorial Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits?Brian Kirkpatrick
Department of Psychiatry, Texas A and M College of Medicine, Temple, TX, USA
Schizophr Bull 38:280-4. 2012..However, other factors merit consideration as potential confounders of this association...- The brief negative symptom scale: psychometric propertiesBrian Kirkpatrick
Department of Psychiatry, Texas A and M College of Medicine, Temple, TX, USA
Schizophr Bull 37:300-5. 2011..93 for the BNSS total score and values of 0.89-0.95 for individual subscales. Comparisons with positive symptoms and other negative symptom instruments supported the discriminant and concurrent validity of the instrument... - Differential patterns of premorbid social and academic deterioration in deficit and nondeficit schizophreniaGregory P Strauss
Department of Psychiatry, University of Maryland School of Medicine, Maryland Psychiatric Research Center, Baltimore, MD 21228, USA
Schizophr Res 135:134-8. 2012.... 
A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapyJohn M Kane
Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY 11004 1150, USA
J Clin Psychiatry 70:1348-57. 2009..Combining antipsychotics is common practice in the treatment of schizophrenia. This study investigated aripiprazole adjunctive to risperidone or quetiapine for treating schizophrenia and schizoaffective disorder...
Olanzapine treatment of residual positive and negative symptomsRobert W Buchanan
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland, Baltimore 21228, USA
Am J Psychiatry 162:124-9. 2005..The authors examined the comparative efficacy and safety of olanzapine and haloperidol in outpatients with partially responsive schizophrenia...- Summer birth and deficit schizophrenia: a pooled analysis from 6 countriesErick Messias
Department of Psychiatry, School of Medicine, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
Arch Gen Psychiatry 61:985-9. 2004..CONCLUSIONS: Deficit schizophrenia has a season of birth pattern that differs from that of nondeficit schizophrenia. This analysis supports the notion of a separate disease within schizophrenia... - Schizophrenia: measurements of psychopathologyJ P Lindenmayer
Department of Psychiatry, New York University, and Manhattan Psychiatric Center, New York, NY, USA
Psychiatr Clin North Am 30:339-63. 2007..The instruments discussed cover the broad range of psychopathology found in patients who have schizophrenia... - DISC1 immunoreactivity at the light and ultrastructural level in the human neocortexBrian Kirkpatrick
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland 21228, USA
J Comp Neurol 497:436-50. 2006..These anatomical localization data suggest that DISC1 participates in synaptic activity and microtubule function, and are consistent with the limited data on its adult function... - Meta-analysis of paternal age and schizophrenia risk in male versus female offspringBrian Miller
Department of Psychiatry, Medical College of Georgia, Augusta, GA 30912, USA
Schizophr Bull 37:1039-47. 2011..Advanced paternal age (APA) is a reported risk factor for schizophrenia in the offspring. We performed a meta-analysis of this association, considering the effect of gender and study design... - Cholesterol and triglycerides in antipsychotic-naive patients with nonaffective psychosisBrian Kirkpatrick
Department of Psychiatry, Texas A and M College of Medicine, Scott and White Healthcare, Temple, TX 76508, United States
Psychiatry Res 178:559-61. 2010..After accounting for gender, age, smoking, socioeconomic status, and body mass index, there was no significant difference between the two groups in total cholesterol, high-density lipoproteins, low-density lipoproteins, or triglycerides... - Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophreniaBrian Kirkpatrick
Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, Maryland, USA
J Nerv Ment Dis 191:563-7. 2003..27 (.10),.53 (.39), and.76 (.20) cells per 10-6 cubic microns. These group differences provide further evidence that deficit and nondeficit schizophrenia differ in their pathophysiology... - Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional statusEran Chemerinski
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Schizophr Res 85:12-9. 2006..J., Gur, R.C., 1991. Relations among clinical scales in schizophrenia. Am. J. Psychiatry 148, 472-478. Brown, K.W., White, T., 1992. Syndromes of chronic schizophrenia and some clinical correlates. Br. J. Psychiatry 161, pp. 317-322]... - Summer birth and deficit schizophrenia: Cantabria, SpainBrian Kirkpatrick
Maryland Psychiatric Research Center, University of Maryland, Department of Psychiatry, P.O. Box 21247, Baltimore 21228, USA
J Nerv Ment Dis 190:526-32. 2002..The existence of a different risk factor for the two groups suggests a difference in etiology and pathophysiology... - Ultrastructural localization of reelin in the cortex in post-mortem human brainRosalinda C Roberts
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland 21228, USA
J Comp Neurol 482:294-308. 2005..The presence of reelin in adult spines, PSD, and terminals suggests that in the adult human reelin has a role in synaptic remodeling, which is consistent with the evidence for its role in long-term potentiation in the adult brain... - Glucocorticoid hormones and early brain development in schizophreniaJames I Koenig
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21228, USA
Neuropsychopharmacology 27:309-18. 2002..These clinical and preclinical studies could be used to develop hypotheses that could then be tested in patients with schizophrenia... - Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trialsRobert P McMahon
Department of Psychiatry, Maryland Psychiatric Research Center, Spring Grove Hospital Grounds, Maple and Locust Avenues, PO Box 21247, Baltimore, MD 21228, USA
Neuropsychopharmacology 26:537-45. 2002..We recommend these four factor scores as clinical trial outcomes in patients with treatment resistant schizophrenia...